Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
Apr. 30, 2024	Apr. 30, 2023
Income Statement [Abstract]
Net sales	$ 203,755	$ 219,494
Cost of products sold	151,704	183,906
Gross profit	52,051	35,588
Operating expenses	33,770	30,224
Operating earnings	18,281	5,364
Pension expense	(4,177)	(71)
Other income, net	814	939
Interest expense	(1,799)	(1,734)
Earnings before income taxes	13,119	4,498
Income tax (benefit) expense	(5,938)	3,139
Net earnings	19,057	1,359
Less: net earnings attributable to the non-controlling interest	304	621
Net earnings attributable to Kewaunee Scientific Corporation	$ 18,753	$ 738
Net earnings per share attributable to Kewaunee Scientific Corporation stockholders
Basic (in usd per share)	$ 6.51	$ 0.26
Diluted (in usd per share)	$ 6.38	$ 0.25
Weighted average number of common shares outstanding
Basic (in shares)	2,879	2,824
Diluted (in shares)	2,938	2,902

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Name:	us-gaap_CostOfGoodsAndServicesSold
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- References

No definition available.